Merck announces Molnupiravir manufacturing in Canada for COVID-19

Merck has announced a partnership with Thermo Fisher Scientific to manufacture Molnupiravir, an oral antiviral medicine for the treatment of COVID-19, in Whitby, Ont. The companies will manufacture Molnupiravir for distribution in Canada and the U.K., as well as markets in Europe, Asia and Latin America, pending local market approvals.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting